Evaxion - PE Ratio 2020-2025 | EVAX
Current and historical p/e ratio for Evaxion - (EVAX) from 2020 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Evaxion - PE ratio as of January 22, 2026 is 0.00.
| Evaxion - PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-01-23 | 4.04 | 0.00 | |
| 2025-09-30 | 3.76 | $-0.32 | 0.00 |
| 2025-06-30 | 2.45 | $-1.25 | 0.00 |
| 2025-03-31 | 1.85 | $-1.09 | 0.00 |
| 2024-12-31 | 4.23 | $-11.30 | 0.00 |
| 2024-09-30 | 15.55 | $-21.30 | 0.00 |
| 2024-06-30 | 14.50 | $-33.60 | 0.00 |
| 2023-06-30 | 65.50 | $-52.50 | 0.00 |
| 2022-06-30 | 96.00 | $-55.50 | 0.00 |
| 2022-03-31 | 151.50 | $-63.50 | 0.00 |
| 2021-12-31 | 221.00 | $-62.50 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.035B | $0.003B |
| Evaxion A/S is a clinical-stage TechBio company specializing in developing AI-Immunology(TM) powered vaccines. Evaxion A/S, formerly known as Evaxion Biotech A/S, is based in COPENHAGEN, Denmark. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.032B | 42.83 |
| Tempus AI (TEM) | United States | $12.162B | 0.00 |
| Doximity (DOCS) | United States | $7.681B | 31.63 |
| Hims & Hers Health (HIMS) | United States | $6.948B | 56.52 |
| IRhythm Holdings (IRTC) | United States | $5.309B | 0.00 |
| Hinge Health (HNGE) | United States | $3.288B | 0.00 |
| Privia Health (PRVA) | United States | $2.947B | 184.31 |
| 10x Genomics (TXG) | United States | $2.935B | 0.00 |
| Heartflow (HTFL) | United States | $2.853B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.348B | 38.85 |
| Omnicell (OMCL) | United States | $2.303B | 47.08 |
| Azenta (AZTA) | United States | $1.886B | 77.38 |
| Clover Health Investments (CLOV) | United States | $1.385B | 0.00 |
| Enovis (ENOV) | United States | $1.347B | 7.07 |
| Schrodinger (SDGR) | United States | $1.277B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.187B | 0.00 |
| Phreesia (PHR) | United States | $0.953B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.871B | 0.00 |
| Talkspace (TALK) | United States | $0.658B | 132.33 |
| Standard BioTools (LAB) | United States | $0.619B | 0.00 |
| Claritev (CTEV) | United States | $0.497B | 0.00 |
| Evolent Health (EVH) | United States | $0.429B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.373B | 0.00 |
| Carlsmed (CARL) | United States | $0.352B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.326B | 0.00 |
| TruBridge (TBRG) | United States | $0.311B | 14.31 |
| Senseonics Holdings (SENS) | United States | $0.307B | 0.00 |
| CapsoVision (CV) | United States | $0.293B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.263B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.196B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.191B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.167B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.163B | 0.00 |
| CareCloud (CCLD) | United States | $0.130B | 7.12 |
| Outset Medical (OM) | United States | $0.098B | 0.00 |
| American Well (AMWL) | United States | $0.081B | 0.00 |
| Pulmonx (LUNG) | United States | $0.079B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.071B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.067B | 0.00 |
| HeartBeam (BEAT) | United States | $0.064B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.060B | 0.00 |
| 111 (YI) | China | $0.046B | 0.00 |
| Precipio (PRPO) | United States | $0.043B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.022B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.019B | 0.00 |
| Zhongchao (ZCMD) | China | $0.012B | 0.00 |
| HeartSciences (HSCS) | United States | $0.011B | 0.00 |
| PROFUSA (PFSA) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.009B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |